{"id":"NCT04341116","sponsor":"I-Mab Biopharma US Limited","briefTitle":"Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)","officialTitle":"A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects With Severe Coronavirus Disease 2019 (COVID-19)","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2020-04-11","primaryCompletion":"2022-02-07","completion":"2022-02-07","firstPosted":"2020-04-10","resultsPosted":"2023-05-06","lastUpdate":"2023-05-06"},"enrollment":149,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Coronavirus Disease 2019 COVID-19"],"interventions":[{"type":"DRUG","name":"TJ003234","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"TJ003234 Medium Dose","type":"EXPERIMENTAL"},{"label":"TJ003234 Low Dose","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"TJ003234 High Dose","type":"EXPERIMENTAL"}],"summary":"This is a randomized, double-blind, placebo-controlled, multi-center trial to evaluate the safety and efficacy of TJ003234 administered as an intravenous (IV) infusion in subjects with severe COVID-19 under supportive care, and to assess the effect of TJ003234 on the levels of cytokines.","primaryOutcome":{"measure":"Percentage of Subjects Alive and Free of Mechanical Ventilation Among Subjects Who Are Free of Mechanical Ventilation at Baseline","timeFrame":"Day 1 through Day 30","effectByArm":[{"arm":"TJ003234 6mg/kg (Part 2)","deltaMin":56,"sd":null},{"arm":"TJ0032034 10mg/kg (Part 2)","deltaMin":5,"sd":null},{"arm":"Placebo (Part 2)","deltaMin":27,"sd":null}],"pValues":[{"comp":"OG002 vs OG003","p":".28"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":14,"countries":["United States"]},"refs":{"pmids":["34473343"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":8},"commonTop":[]}}